Along with rapid weight loss, patients see other benefits and risks of GLP-1 drugs WPECGLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis NatureResearchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target statnews.comReport: A Common Medication Reduced Heart Risk By 14% and Diabetes Risk by 30% The Healthy @Reader’s DigestWhat I Wish I Knew About Obesity Treatment Health: Trusted and Empathetic Health and Wellness Information